Professional Documents
Culture Documents
Myotonic Dystrophy Research Feb 2 2019
Myotonic Dystrophy Research Feb 2 2019
Ms. Sappington
Honors Biology
Feb 2, 2019
the most common form of muscular dystrophy that usually begins in adulthood. Myotonic
dystrophy is characterized by progressive muscle weakness. People with this disorder often have
prolonged muscle contractions, also known as myotonia, and are not able to relax certain
muscles after use. For example, a person may have difficulty releasing their grip on a doorknob
or handle. Also, affected people may have stuttered or temporary locking of their jaw. In which
Signs and symptoms of myotonic dystrophy include: burry image, random abnormalities
of the electrical signals that control the heartbeat and in males, hormonal changes may lead to
early balding and the inability to reproduce in some cases. You also will experience weak
muscles throughout the body and the inability in some cases to walk and to lift objects like a cup
There are specifically two types of myotonic dystrophy. More often called myotonic
dystrophy type 1 and myotonic dystrophy type 2. Abbreviated as DM 1 and DM 2, people are
usually classified into these groups due to their geographic and ethnic populations. Type 1’s
symptoms tend to be more harsh than type 2’s. The muscle weakness of type 1 affects your lower
body from your feet to our waist and type two affects the upper body from the waist to the
shoulders
Some interesting facts about myotonic dystrophy are that it affects nearly 1 in every
8,000 people worldwide. The type of Myotonic Dystrophy type 1 and type two all depend on the
geographic area you live in. The presence of the two types of the disorder vary among different
geographic and ethnic populations. In many populations, type 1 appears to be more prevalent
than type 2. It is usually abbreviated as DM not MD or MD1 and MD2 (type 1 and 2). It affects
Myotonic dystrophy was found by Hans Steinert, who in 1909 originally named it
Steinert disease, in which many refer to today, however it is most commonly known as myotonic
dystrophy and scientists across the world. Without his research we could have been waiting for
years for us to understand the disorder. The disorder is similar to muscular dystrophy however,
“Muscular dystrophy (MD) refers to a group of nine genetic diseases that cause progressive
weakness and degeneration of muscles used during voluntary movement” (MDF 1).
According to The Myotonic Dystrophy Foundation, “Both DM1 and DM2 are passed
from parent to child by autosomal dominant mutations. This means that the faulty gene is located
on an autosome and that only a dominant allele is needed for Myotonic dystrophy to show”
(MDF 2). Which makes it a dominantly affected trait. And because the gene is not located on any
of the sex chromosomes, it can be passed to any of the offspring. Furthermore, DM1 is located
signs and symptoms become more severe. This phenomenon, called anticipation, has been
reported with both types of myotonic dystrophy. As I mentioned earlier it affects certain
Geographical regions however, research done in the 21st century has conducted a study that
shows many Finish and German people that both have DM2. Most people starts to get DM1 and
DM2’s symptoms at the age of 60. And is one of nine forms of muscular dystrophies that occur
dystrophy. Ankle supports and leg braces can help when muscle weakness gets worse. There are
also medications that can lessen the myotonia.” This is especially frightening as this is only one
Getting an initial diagnosis starts with a complete family history and physical
examination. Usually someone will undergo a string of medical tests. If the diagnosis tests
negative, another process is electromyography, also known as EMG, and this procedure detects
the presence of myotonia in high proportion including DM1 and DM2. However, more
importantly to confirm the finding a blood test is needed to see if that person has the mutation.
Researchers at The Scripps Research Institute in Florida recently created a new chemical
modification to increase the potency of a medicine that targets the unhealthy RNA associated
with DM. Secondly, scientists from Baylor College of Medicine have investigated defects that
occur in muscles of individuals with DM1. However other than this, there isn’t much research
being undergone.
I will be showing a pedigree on my PowerPoint and I will also show a cross between
Steinberg, H, and A Wagner. “[Hans Steinert: 100 Years of Myotonic Dystrophy].” Current
Neurology and Neuroscience Reports., U.S. National Library of Medicine, Aug. 2008,
www.ncbi.nlm.nih.gov/pubmed/18566789.
“Myotonic Dystrophy.” Genetic and Rare Diseases Information Center, U.S. Department of
www.rarediseases.info.nih.gov/diseases/10419/myotonic-dystrophy
“Learning About Myotonic Dystrophy.” National Human Genome Research Institute (NHGRI),
www.genome.gov/25521207/learning-about-myotonic-dystrophy/.
Dystrophy Foundation, Myotonic. “Testing and Diagnosis.” Testing and Diagnosis for DM, The
and-diagnosis.
K., Haley. “Current DM Research Update.” Current Research of DM, The Myotonic Dystrophy